Artelo Biosciences Inc. (ARTL)
NASDAQ: ARTL
· Real-Time Price · USD
4.35
-4.41 (-50.34%)
At close: Sep 04, 2025, 3:59 PM
4.53
4.14%
Pre-market: Sep 05, 2025, 06:08 AM EDT
-50.34% (1D)
| Bid | 3.2 |
| Market Cap | 3.06M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.5M |
| EPS (ttm) | -18.93 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | -1.07 |
| Analyst | Buy |
| Ask | 5.44 |
| Volume | 581,603 |
| Avg. Volume (20D) | 682,281 |
| Open | 4.39 |
| Previous Close | 8.76 |
| Day's Range | 4.20 - 4.66 |
| 52-Week Range | 4.20 - 28.60 |
| Beta | 1.36 |
About ARTL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARTL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ARTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
-50.34%
Artelo Biosciences shares are trading lower after ...
Unlock content with
Pro Subscription
1 month ago
-14%
ARTL stock has given up its prior gain. Artelo Biosciences shares were trading higher after the company received written scientific advice from the UK MHRA affirming the proposed design for its Phase 1 trial of ART12.11.
